Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioTek Launches Enhanced SiLA Compliant Software

Published: Tuesday, July 08, 2014
Last Updated: Tuesday, July 08, 2014
Bookmark and Share
BioTek’s LHC™ SiLA software for washers/dispensers.

LHC™ SiLA is a Liquid Handling Control Software that allows any BioTek LHC-controlled washer or dispenser to be integrated into a robotic system with SiLA compliance, equipping users with more flexibility in system configuration compared to conventional instrument drivers.

Compatible instruments include EL406, 405 Touch, 405 LS, ELx405 Select Deep Well, MultiFlo and MultiFlo FX. BioTek's LHC™ SiLA driver was developed in accordance with the Consortium for Standardization in Lab Automation's published set of universal methods for microplate washers and dispensers.

Important benefits include:
• Total flexibility in instrument component and automated system selection-users choose the best instrument for assay vs. being limited to what can be integrated into current systems.
• Fast, cost effective and seamless integration with automated systems.
• Conforms to international standards set forth by the Consortium for Standardization in Lab Automation creating open connectivity in lab automation.

The Consortium for Standardization in Lab Automation (more commonly known as SiLA) develops and introduces new interface and data management standards allowing rapid integration of lab automation systems. SiLA's mission is to establish international standards which create open connectivity in lab automation.

SiLA is a not-for-profit membership corporation with a global footprint open to institutions, corporations and individuals active in the life science lab automation industry.

SiLA compliance is quickly becoming a requirement for new instrument purchases in the labs of major pharmaceutical companies.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!